title: Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
abstract: Ivabradine is the first selective and specific inhibitor of the I(f) current (the cardiac pacemaker 'funny' current), and provides pure heart rate reduction without altering myocardial contractility, the cardiac conduction system or coronary vascular resistance. Clinical proof of the antianginal efficacy and tolerability of ivabradine comes from the largest clinical development programme that has ever been performed in stable angina, involving more than 5000 patients. Ivabradine was shown to be as effective as well-established reference antianginal drugs, such as beta-blockers and calcium antagonists. It is well tolerated and is free of the most commonly observed side effects of currently prescribed antianginal drugs. It offers clear therapeutic benefits for a whole range of patients with stable angina, including those with contraindications or intolerance to beta-blockers.
authors.affiliation: Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK. k.fox@rbh.nthames.nhs.uk
authors.forename: Kim
authors.initials: K
authors.lastname: Fox
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001552:Benzazepines / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006339:Heart Rate; D006801:Humans; D000077550:Ivabradine; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D009566:Nitrates / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D012849:Sinoatrial Node / Q000187:drug effects / Q000503:physiopathology
chemical_list: D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D009566:Nitrates; D000077550:Ivabradine